Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: Application to m-iodobenzylguanidine

Bioconjugate Chemistry

Volumn 9, Issue 6, 1998, Pages 758-764

  Vaidyanathan, Ganesan ^a   Zalutsky, Michael R ^a   DeGrado, Timothy R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODIES; PYRIDINE; TUMORS;

ACYLATIONS; BENZENE RING; IODOBENZENE; LOW MOLECULAR WEIGHT; NEUROENDOCRINE TUMORS; NORMAL TISSUE; PYRIDINE RINGS; SILICON PRECURSORS; SYNTHESISED; TUMOR THERAPY;

BENZENE;

EID: 0032213077     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980037x     Document Type: Article

References (28)

1. Babich, J. W., Graham, W. A., and Fischman, A. J. (1996) Evaluation of phenylpiperazines as targeting agents for neuroblastoma. Br. J. Cancer 74, 917-924.
2. Biedler, J. N., Helson, L., and Spengler, B. A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
3. Bluhm, L. H., and Li., T. (1998) Chromatographic purification of quaternary ammonium and pyridinium compounds on normal phase silica gel. Tetrahedron Lett. 39, 3623-3626.
4. 125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res. 45, 6366-6370.
5. Chan, S. M., Basmadjian, G. P., Marten, D. F., Sadek, S., Magarian, R. A., Grunder, J. R., and Ice, R. D. (1983) Synthesis and biodistribution of radioiodinated 5-iodonicotine. J. Nuclear Med. 24, P116 (Abstract).
6. DeGrado, T. R., Zalutsky, M. R., and Vaidyanathan, G. (1995) Uptake mechanisms of meta-iodobenzylguanidine Nuclear Med. Biol. 22, 1-12.
7. Dodd, D. S., and Kozikowski, A. P. (1994) Conversion of alcohols to protected guanidines using the Mitsunobu protocol. Tetrahedron Lett. 35, 977-980.
8. Foulon, C. F., Alston, K. L., and Zalutsky, M. R. (1997) Synthesis and preliminary biological evaluation of (3-iodobenzoyl)-norbiotinamide and ((5-iodo-3-pyridinyl)carbonyl)norbiotinamide: Two radioiodinated biotin conjugates with improved stability. Bioconjugate Chem. 8, 179-186.
9. Garg, S., Garg, P. K., and Zalutsky, M. R. (1991) N-Succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylate: A new class of reagents for protein radioiodination. Bioconjugate Chem. 2, 50-56.
10. Garg, S., Garg, P. K., and Zalutsky, M. R. (1992) Acylation agents for the radiohalogenation of peptides. J. Labeled Compd. Radiopharm. 32, 212 (Abstract).
11. Garg, S., Garg, P. K., Zhao, X.-G., Friedman, H. S., Bigner, D. D., and Zalutsky, M. R. (1993) Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Nuclear Med. Biol. 20, 835-842.
12. Hanson, R. N. (1982) Radioiodinated 1-carboxamidino-4-phenylpiperazine: A potential adrenal and myocardial imaging radiopharmaceutical. Int. J.Appl. Radiat. Isot. 33, 629-632.
13. Hanson, R. N. (1983) Preparation and evaluation of radioiodinated phenylpiperazines as adrenomedullary imaging agents. Int. J. Nucl. Med. Biol. 10, 219-222.
14. Iversen, L. L., Salt, P. J., and Wilson, H. A. ( 1972) Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine. Br. J. Pharm. 46, 647-657.
15. Jaques, S., Jr., Tobes, M. C., and Sisson, J. C. (1987) Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res. 47, 3920-3928.
16. Kaltenbach, J. P., Kaltenbach, M. H., and Lyons, W. B. (1958) Nigrosin as a dye for differentiating live and dead ascites cells. Exp. Cell Res. 15, 112-117.
17. Lane, C. F., Myatt, H. L., Daniels, J., and Hopps, H. B. (1974) Organic synthesis using borane-methyl sulfide. II. Reduction of aromatic carboxylic acids in the presence of trimethyl borate. J. Org. Chem. 39, 3052-3054.
18. Moerlein, S. M. (1990) Regiospecific aromatic radioiodination via no-carrier-added copper(I)chloride-assisted iododebromination. Radiochim. Acta 50, 55-61.
19. Reist, C. J., Garg, P. K., Alston, K. L., Bigner, D. D., and Zalutsky, M. R. (1996) Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Cancer Res. 56, 4970-4977.
20. Smets, L. A., Bout, B., and Wisse, J. (1988) Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodobenzylguanidine (MIBG). Cancer Chemother. Pharmacol 21 9-13.
21. Smets, L. A., Loesberg, C., Janssen, M., Metwally, E. A., and Huiskamp, R. (1989) Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res. 49, 2941-2944.
22. Smets, L. A., Janssen, M., Metwally, E., and Loesberg, C. (1990) Extragranular storage of the neuron blocking agent metaiodobenzylguanidine (MIBG) in human neuroblastoma cells. Biochem. Pharmacol. 39, 1959-1964.
23. Still, C. W., Kahn, M., and Mitra, A. (1978) Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 43, 2923-2925.
24. 131I]iodobenzylguanidine. Appl. Radiat. Isot. 44, 621-628.
25. 18F]Fluoro-3-iodobenzylguanidine: A potential MIBG analogue for positron emission tomography. J. Med. Chem. 37, 3655-3662.
26. 131I]iodobenzylguanidine: Evaluation of an MIBG analogue. J. Nuclear Med. 38, 330-334.
27. Wieland, D. M. (1986) Radiopharmaceutical Design: The adrenal medulla and its diseases. In Radiopharmaceuticals: Progress and Clinical Perspectives (A. R. Fritzberg, Ed.) Vol. 1, pp 117-153, CRC Press, Inc., Boca Raton, FL.
28. Yong, Y. F., Kowalski, J. A., and Lipton, M. A. (1997) Facile and efficient guanylation of amines using thioureas and Mukaiyama's reagent. J. Org. Chem. 62, 1540-1542.